Home > Journals > Minerva Gastroenterology > Past Issues > Articles online first > Minerva Gastroenterology 2021 Jul 19

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Gastroenterology 2021 Jul 19

DOI: 10.23736/S2724-5985.21.02921-1

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Safety of bevacizumab combined with chemotherapy in the treatment of recurrent ovarian cancer and its effect on adverse reactions and digestive function

Ping JIA 1, Suwen CHANG 2, Yanan ZHANG 3, Ruifang TANG 4, Xing LIU 5, Yingjia XU 6, Aimin LIANG 7

1 Department of Obstetrics and Gynecology, Xiangyang No.1 People’s Hospital Affiliated Hospital of Hubei University of Medicine, Xiangyang, China; 2 Department of Gynaecology, Yantai Yuhuangding Hospital, Yantai, China; 3 Department of Nursing, People’s Hospital of Xiangzhou District, Xiangyang, China; 4 Dongfeng Emergency Station, Xiangyang Emergency Center, Xiangyang, China; 5 Department of Neurosurgery, Xiangyang No.1 People’s Hospital Affiliated Hospital of Hubei University of Medicine, Xiangyang, China; 6 Department of Nursing, Institute of Medicine and Nursing, Hubei University of Medicine, Shiyan, China; 7 UCC, Xiangyang No.1 People’s Hospital Affiliated Hospital of Hubei University of Medicine, Xiangyang, China


PDF


top of page